Suchergebnisse - "Lundmark, Fanny"

PubPharm (7)

1

Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linker

enthalten in: Molecular medicine reports | 2024

von Lundmark, F. | Vorobyeva, A. | Liu, Y. | +6

2

The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial : Kit Preparation, Characterization and Toxicity

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Abouzayed, A. | Borin, J. | Lundmark, F. | +6

3

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

enthalten in: Frontiers in oncology | 2023

von Abouzayed, A. | Seitova, K. | Lundmark, F. | +5

4

Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer : A Step towards Clinical Translation

enthalten in: Cancers | 2023

von Lundmark, F. | Abouzayed, A. | Rinne, S. | +9

5

Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands

enthalten in: Pharmaceutics | 2022

von Lundmark, F. | Olanders, G. | Rinne, S. | +3

6

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

enthalten in: Pharmaceutics | 2020

von Lundmark, F. | Abouzayed, A. | Mitran, B. | +6

7

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart

enthalten in: Pharmaceutics | 2019

von Oroujeni, M. | Abouzayed, A. | Lundmark, F. | +4

1
[1]